Cancer research gets $825K boostOctober 16, 2020America’s top veterinarian oncology universities have received additional funding to help in the fight against pet cancer.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Ohio State opens expanded veterinary oncology suiteMay 29, 2019Ohio State University's Veterinary Medical Center has opened the Blue Buffalo Foundation Integrated Oncology Suite, allowing practitioners to comprehensively and holistically treat pets with cancer. Blue Buffalo granted the school $650,000 to renovate the suite. "Blue Buffalo was founded on a mission to help cure a disease causing 50 percent of health-related pet deaths," says the company's vice president, David Petrie. "In supporting the renovation of the integrated oncology space, we are able to support veterinary medicine so dogs and cats facing cancer can receive a cohesive team approach, resulting in better health outcomes." The suite's team comprises veterinarians with specialties in medical, surgical, and radiation oncology. Clinical trials also are a big part of the integrated oncology service and are managed by the Blue Buffalo Veterinary Clinical Trials Office. The company's funding will help support animals enrolled in a study. "Our partnership with Blue Buffalo has made it possible to provide studies that test new diagnostics and treatments across a wide spectrum of pet health, including cancer, renal failure, heart disease, and arthritis," says Cheryl London, DVM, PhD, clinical trials office director and professor of veterinary biosciences. "Clinical trials in veterinary medicine are critical for identifying new approaches to …
Veterinary oncology market profiled in new Brakke Consulting reportSeptember 15, 2017Brakke Consulting in Dallas has announced the release of a new study that profiles the veterinary oncology sector. "Oncology is one of the highest interest areas in veterinary medicine today," said Lynn Fondon DVM, a senior consultant at Brakke Consulting. "In the past decade, the U.S. has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development." The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented. It estimates the current sales of veterinary-approved cancer therapies, as well as provides estimates of the total number of pets treated with chemotherapy or immunotherapy. "We surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer," said Dr. Fondon. The report, …
